Gossamer Bio, Inc. - Common Stock (GOSS)

Q2 2019 13F Holders as of 6/30/2019

Type / Class
Equity / Common Stock
Shares outstanding
227M
Number of holders
72
Total 13F shares, excl. options
36.7M
Shares change
+1.3M
Total reported value, excl. options
$812M
Value change
+$29.1M
Number of buys
38
Number of sells
-32
Price
$22.18

Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q2 2019

83 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q2 2019.
Gossamer Bio, Inc. - Common Stock (GOSS) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 36.7M shares of 227M outstanding shares and own 16.13% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (6.95M shares), HILLHOUSE CAPITAL MANAGEMENT, LTD. (4.97M shares), Capital International Investors (3.28M shares), BOXER CAPITAL, LLC (1.88M shares), VANGUARD GROUP INC (1.63M shares), ALLIANCEBERNSTEIN L.P. (1.62M shares), Artal Group S.A. (1.61M shares), BlackRock Inc. (1.3M shares), BAUPOST GROUP LLC/MA (1.27M shares), and FMR LLC (1.04M shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.